Extended-spectrum beta-lactamases in ceftazidime-resistant Escherichia coli and Klebsiella pneumoniae isolates in Turkish hospitals

Indian Journal of Medical Microbiology

Volumn 25, Issue 4, 2007, Pages 346-350

  Hosoglu S ^a   Gundes, S ^b   Kolayli, F ^b   Karadenizli, A ^b   Demirdag K ^c   Gunaydin, M ^d   Altindis, M ^e   Caylan R ^f   Ucmak, H ^a  

^a DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b KOCAELI UNIVERSITY   (Turkey)

^c FIRAT UNIVERSITY   (Turkey)

^d Ondokuzmayis University Hospital   (Turkey)

^e Afyon Kocatepe Universitesi Rektorluk Ahmet Necdet Sezer Arastirma ve Uygulama Hastanesi   (Turkey)

^f KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Ceftazidime resistant; E. coli; ESBL; GES; Klebsiella; SHV; TEM

Indexed keywords

BETA LACTAMASE GES; BETA LACTAMASE SHV; BETA LACTAMASE TEM 1; CARBAPENEM; CEFTAZIDIME; EXTENDED SPECTRUM BETA LACTAMASE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BETA LACTAMASE GES GENE; BETA LACTAMASE SHV GENE; BETA LACTAMASE TEM 1 GENE; CONTROLLED STUDY; DRUG SENSITIVITY; ESCHERICHIA COLI; GENE; ISOELECTRIC FOCUSING; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; UNIVERSITY HOSPITAL;

EID: 37549009519     PISSN: 02550857     EISSN: 02550857     Source Type: Journal    
DOI: 10.4103/0255-0857.37336     Document Type: Article

References (23)

1. Bradford PA. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology and detection of this important resistance threat. Clin Microbiol Rev 2001;14:933-51.
2. Gniadkowski M, Schneider I, Jungwirth R, Hryniewicz W, Bauernfeind A. Ceftazidime-resistant Enterobacteriaceae isolates from three polish hospitals: Identification of three novel TEM- and SHV-5-type extended-spectrum β-lactamases. Antimicrob Agents Chemother 1998;42:514-20.
3. Kliebe C, Nies BA, Meyer JF, Tolxdorff-Neutzling RM, Wiedemann B. Evolution of plasmid-coded resistance to broad spectrum cephalosporins. Antimicrob Agents Chemother 1985;28:302-7.
4. Bush K, Jacoby GA, Medeiros AA. Functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995;39:1211-33.
5. Jacoby GA, Medeiros AA. More extended-spectrum β-lactamases. Antimicrob Agents Chemother 1991;35:1697-704.
6. Philippon A, Arlet G, Lagrange PH. Origin and impact of plasmid-mediated extended-spectrum β-lactamases. Eur J Clin Microbiol Infect Dis 1994;13:S17-29.
7. Baraniak A, Fiett J, Sulikowska A, Hryniewicz W, Gniadkowski M. Countrywide spread of CTX-M-3 extended-spectrum β-lactamase-producing microorganisms of the family Enterobacteriaceae in Poland. Antimicrob Agents Chemother 2002;46:151-9.
8. Barthelemy M, Peduzzi J, Bernard H, Tancrede C, Labia R. Close amino acid sequence relationship between the new plasmid-mediated extended-spectrum β-lactamase MEN-1 and chromosomally encoded enzymes of Klebsiella oxytoca. Biochim Biophys Acta 1992;1122:15-22.
9. Wachino JL, Doi Y, Yamane K, Shibata N, Yagi T, Kubota T, et al. Nosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel class A β-lactamase, GES-3, in a neonatal intensive care unit in Japan. Antimicrob Agents Chemother 2004;48:1960-7.
10. Wachino JL, Doi Y, Yamane K, Shibata N, Yagi T, Kubota T, et al. Molecular characterization of a cephamycin-hydrolyzing and inhibitor-resistant class A β-lactamase, GES-4, possessing a single G170S substitution on the -loop. Antimicrob Agents Chemother 2004;48:2905-10.
11. Vourli S, Giakkoupi P, Miriagou V, Tzelepi E, Vatopoulos AC, Tzouvelekis LS. Novel GES/IBC extended-spectrum beta-lactamase variants with carbapenemase activity in clinical enterobacteria. FEMS Microbiol Lett 〈javascript: AL_get(this,%20.jour.,%20.FEMS%20Microbiol%20Lett..);〉 2004;234:209-13.
12. Durmaz R, Durmaz B, Koroglu M, Tekerekoglu MS. Detection and typing of extended-spectrum β-lactamases in clinical isolates of the family Enterobacteriaceae in a medical center in Turkey. Microb Drug Resist 2001;7:171-5.
13. Paterson DL, Ko WC, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, et al. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum β-lactamase production in nosocomial Infections. Ann Intern Med 2004;140:26-32.
14. th Informational Supplement. M100-S12. NCCLS: Wayne; 2002.
15. Vahaboglu H, Ozturk R, Aygun G, Coskunkan F, Yaman A, Kaygusuz A, et al. Widespread detection of PER-1-type extended-spectrum beta-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: A nationwide multicenter study. Antimicrob Agents Chemother 1997;41:2265-9.
16. Matthew M, Harris AM, Marshall MJ, Ross GW. The use of analytic isoelectric focusing for detection and identification of β-lactamases. J Gen Microbiol 1975;88:169-78.
17. Palucha A, Mikiewicz B, Hryniewicz M, Gniadkowski M. Concurrent outbreaks of extended-spectrum β-lactamase-producing organisms of the family Enterobacteriaceae in a Warsaw hospital. J Antimicrob Chemother 1999;44:489-99.
18. Giamarellou H. Multidrug resistance in gram-negative bacteria that produce extended-spectrum β-lactamases (ESBLs). Clin Microbiol Infect 2005;11:1-16.
19. Leblebicioglu H, Gunaydin M, Esen S, Tuncer I, Findik D, Ural O, et al. Surveillance of antimicrobial resistance in Gram-negative isolates from intensive care units in Turkey: Analysis of data from the last 5 years. J Chemother 2002;14:140-6.
20. Yaman A, Tasova Y, Kibar F, Inal AS, Saltoglu N, Buyukcelik O, et al. Investigation of the antibiotic susceptibility patterns of pathogens causing nosocomial infections. Saudi Med J 2004;25:1403-9.
21. Ozgunes I, Erben N, Kiremitci A, Kartal ED, Durmaz G, Colak H, et al. The prevalence of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in clinical isolates and risk factors. Saudi Med J 2006;27:608-12.
22. Cagatay AA, Kocagoz T, Eraksoy H. Dio-Sensimedia: A novel culture medium for rapid detection of extended spectrum β-lactamases. BMC Infect Dis 2003;3:22.
23. Acikgoz ZC, Gulay Z, Bicmen M, Gocer S, Gamberzade S. CTX-M-3 extended-spectrum β-lactamase in a Shigella sonnei clinical isolate: First report from Turkey. Scand J Infect Dis 2003;35:503-5.